PROX1 and thyroid cancer, nonmedullary, 2: Comparably, in follicular thyroid cancer (FTC), the overexpression of Prospero homeobox 1 (PROX1), a key regulator of lymphangiogenesis, resulted in a decrease in several FGF signaling pathway members, including the downregulation of bFGF [162].